Share on StockTwits

GI Dynamics (ASX:GID)‘s stock had its “add” rating restated by equities researchers at CIMB in a research report issued on Wednesday. They currently have a $1.04 target price on the stock.

GI Dynamics (ASX:GID) traded up 1.23% on Wednesday, hitting A$0.410. 914,792 shares of the company’s stock traded hands. GI Dynamics has a 1-year low of A$0.395 and a 1-year high of A$0.980. The stock’s 50-day moving average is A$0.50 and its 200-day moving average is A$0.59. The company’s market cap is A$167.1 million.

GI Dynamics, Inc is the developer and marketer of EndoBarrier, a device that represents an entirely new class of non-surgical, non-pharmaceutical therapy for the treatment of type 2 diabetes and obesity.

Receive News & Ratings for GI Dynamics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GI Dynamics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.